efficacious < efficacy < efficiency

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by efficacy

Number of relevant bibliographic references: 34.
[0-20] [0 - 20][0 - 34][20-33][20-40]

Ident.	Authors (with country if any)	Title
000187 (2020)	Nathan Ford ; Marco Vitoria ; Ajay Rangaraj ; Susan L. Norris ; Alexandra Calmy ; Meg Doherty	Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment
000252 (2020)	Rong Chen [République populaire de Chine] ; Yuan Zhang [République populaire de Chine] ; Lei Huang [République populaire de Chine] ; Bi-Heng Cheng [République populaire de Chine] ; Zhong-Yuan Xia [République populaire de Chine] ; Qing-Tao Meng [République populaire de Chine]	Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients
000964 (2020)	Jianjun Gao [République populaire de Chine] ; Zhenxue Tian [République populaire de Chine] ; Xu Yang [République populaire de Chine]	Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
000A19 (2020)	Andrea Cortegiani [Italie] ; Giulia Ingoglia [Italie] ; Mariachiara Ippolito [Italie] ; Antonino Giarratano [Italie] ; Sharon Einav [Israël]	A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.
000C71 (2018)	Maren Eggers [Allemagne] ; Torsten Koburger-Janssen [Allemagne] ; Markus Eickmann [Allemagne] ; Juergen Zorn [Allemagne]	In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens
000C88 (2018)	Sandra G. Steele [Australie] ; Robert Booy [Australie] ; Siobhan M. Mor [Australie]	Establishing research priorities to improve the One Health efficacy of Australian general practitioners and veterinarians with regard to zoonoses: A modified Delphi survey.
001789 (2014)	S. M. Goyal [États-Unis] ; Y. Chander [États-Unis] ; S. Yezli [Royaume-Uni] ; J. A. Otter [Royaume-Uni]	Evaluating the virucidal efficacy of hydrogen peroxide vapour
001818 (2013)	Abid Qureshi ; Nishant Thakur ; Manoj Kumar [Inde]	VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses.
001918 (2013)	Jie Li [États-Unis] ; Laura Ulitzky ; Erica Silberstein ; Deborah R. Taylor ; Raphael Viscidi	Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates.
002004 (2011)	V N Shchukina ; S Ia Loginova ; S V Borisevich ; V P Bondarev	[Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome].
002308 (2011)	Eric Fong [Canada] ; Ly-Yun Chang [Taïwan]	Community Under Stress: Trust, Reciprocity, and Community Collective Efficacy During SARS Outbreak
002523 (2010)	Anjeanette Roberts [États-Unis] ; Elaine W. Lamirande ; Leatrice Vogel ; Benoît Baras ; Geneviève Goossens ; Isabelle Knott ; Jun Chen ; Jerrold M. Ward ; Ventzislav Vassilev ; Kanta Subbarao	Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine.
002575 (2010)	Barry R. O'Keefe [États-Unis] ; Barbara Giomarelli ; Dale L. Barnard ; Shilpa R. Shenoy ; Paul K S. Chan ; James B. Mcmahon ; Kenneth E. Palmer ; Brian W. Barnett ; David K. Meyerholz ; Christine L. Wohlford-Lenane ; Paul B. Mccray	Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae.
002875 (2010)	Mohsin Khan [Inde] ; S. R. Santhosh [Inde] ; Mugdha Tiwari [Inde] ; P. V. Lakshmana Rao [Inde] ; Manmohan Parida [Inde]	Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against chikungunya virus in vero cells
002947 (2010)	Barry R. O'Keefe [États-Unis] ; Barbara Giomarelli [États-Unis] ; Dale L. Barnard [États-Unis] ; Shilpa R. Shenoy [États-Unis] ; Paul K. S. Chan [Hong Kong] ; James B. Mcmahon [États-Unis] ; Kenneth E. Palmer [États-Unis] ; Brian W. Barnett [États-Unis] ; David K. Meyerholz [États-Unis] ; Christine L. Wohlford-Lenane [États-Unis] ; Paul B. Jr Mccray [États-Unis]	Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae
003307 (2008)	Onno De Zwart [Pays-Bas] ; Irene K. Veldhuijzen [Pays-Bas] ; Gillian Elam [Royaume-Uni] ; Arja R. Aro [Danemark] ; Thomas Abraham [Hong Kong] ; George D. Bishop [Singapour] ; Hélène A. C. M. Voeten [Pays-Bas] ; Jan Hendrik Richardus [Pays-Bas] ; Johannes Brug [Pays-Bas]	Perceived Threat, Risk Perception, and Efficacy Beliefs Related to SARS and Other (Emerging) Infectious Diseases: Results of an International Survey
003470 (2008)	Raymond H. See [Canada] ; Martin Petric [Canada] ; David J. Lawrence [Canada] ; Catherine P. Y. Mok [Canada] ; Thomas Rowe [États-Unis] ; Lois A. Zitzow [États-Unis] ; Karuna P. Karunakaran [Canada] ; Thomas G. Voss [États-Unis] ; Robert C. Brunham [Canada] ; Jack Gauldie [Canada] ; B. Brett Finlay [Canada] ; Rachel L. Roper [États-Unis]	Severe acute respiratory syndrome vaccine efficacy in ferrets : whole killed virus and adenovirus-vectored vaccines
003491 (2008)	Dale L. Barnard [États-Unis] ; Craig W. Day [États-Unis] ; Kevin Bailey [États-Unis] ; Matthew Heiner [États-Unis] ; Robert Montgomery [États-Unis] ; Larry Lauridsen [États-Unis] ; Kie-Hoon Jung [États-Unis] ; Joseph K.-K. Li [États-Unis] ; Paul K. S. Chan [Hong Kong] ; Robert W. Sidwell [États-Unis]	Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse model
003511 (2008)	Arun K. Ghosh [États-Unis] ; GANGLI GONG [États-Unis] ; Valerie Grum-Tokars [États-Unis] ; Debbie C. Mulhearn [États-Unis] ; Susan C. Baker [États-Unis] ; Melissa Coughlin [États-Unis] ; Bellur S. Prabhakar [États-Unis] ; Katrina Sleeman [États-Unis] ; Michael E. Johnson [États-Unis] ; Andrew D. Mesecar [États-Unis]	Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors
003694 (2007)	Benoît Callendret [France] ; Valérie Lorin [France] ; Pierre Charneau [France] ; Philippe Marianneau [France] ; Hugues Contamin [France] ; Jean-Michel Betton [France] ; Sylvie Van Der Werf [France] ; Nicolas Escriou [France]	Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS
003739 (2007)	Damon Deming ; Timothy Sheahan ; Mark Heise ; Boyd Yount ; Nancy Davis ; Amy Sims ; Mehul Suthar ; Jack Harkema ; Alan Whitmore ; Raymond Pickles ; Ande West ; Eric Donaldson ; Kristopher Curtis ; Robert Johnston ; Ralph Baric	Correction: Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "efficacy" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "efficacy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    efficacy
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021